Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution

Materials Science and Engineering C

Volumn 71, Issue , 2017, Pages 584-593

  Tran, Nhiem ^a,b,c   Bye, Nicole ^d   Moffat, Bradford A ^d   Wright, David K ^d,e   Cuddihy, Andrew ^f   Hinton, Tracey M ^a   Hawley, Adrian M ^b   Reynolds, Nicholas P ^a,g   Waddington, Lynne J ^a   Mulet, Xavier ^a   Turnley, Ann M ^d   Morganti Kossmann, M Cristina ^h,i   Muir, Benjamin W ^a  

^a CSIRO   (Australia)

^b AUSTRALIAN SYNCHROTRON   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^h MONASH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Biodistribution; Cubosome; Hexosome; Imaging; Lipid; MRI; Multifunctional; Nanoparticles

Indexed keywords

DIAGNOSIS; IMAGING TECHNIQUES; INFRARED DEVICES; LIPID BILAYERS; LIPIDS; LIQUID CRYSTALS; MAGNETIC RESONANCE; NANOPARTICLES; NEMATIC LIQUID CRYSTALS; THROUGHPUT;

BIODISTRIBUTIONS; CUBOSOMES; ENGINEERED NANOPARTICLES; HEXOSOME; HIGH THROUGHPUT SCREENING; MULTIFUNCTIONAL; NANOPARTICLE FORMULATION; NEAR-INFRARED FLUORESCENT;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; NANOPARTICLE;

ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; FLUORESCENCE IMAGING; HUMAN; MALE; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; U-937 CELL LINE;

ANIMALS; CHO CELLS; CONTRAST MEDIA; CRICETULUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; NANOPARTICLES; OPTICAL IMAGING; U937 CELLS;

EID: 85006049030     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.10.028     Document Type: Article

References (57)

1. [1] Pressly, E.D., Pierce, R.A., Connal, L.A., Hawker, C.J., Liu, Y., Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer. Bioconjug. Chem. 24 (2013), 196–204.
2. [2] Luehmann, H.P., Detering, L., Fors, B.P., Pressly, E.D., Woodard, P.K., Randolph, G.J., Gropler, R.J., Hawker, C., Liu, Y., PET/CT imaging of chemokine receptors in inflammatory atherosclerosis using targeted nanoparticles. J. Nucl. Med., 2016 (DOI jnumed. 115.166751).
3. [3] Abadjian, M.-C., Latoche, J., Thomas, E., Foley, L., Day, K., Lux, F., Tillement, O., Hitchens, T.K., Anderson, C., PET and MR imaging with 64Cu/68Ga-labeled AGuIX ultra-small nanoparticles in tumor-bearing mice. J. Nucl. Med., 57, 2016, 1181.
4. [4] Majmudar, M.D., Yoo, J., Keliher, E.J., Truelove, J.J., Iwamoto, Y., Sena, B., Dutta, P., Borodovsky, A., Fitzgerald, K., Di Carli, M.F., Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ. Res. 112 (2013), 755–761.
5. [5] Cheng, L., Yang, K., Li, Y., Zeng, X., Shao, M., Lee, S.-T., Liu, Z., Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 33 (2012), 2215–2222.
6. [6] Xing, H., Bu, W., Zhang, S., Zheng, X., Li, M., Chen, F., He, Q., Zhou, L., Peng, W., Hua, Y., Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 33 (2012), 1079–1089.
7. [7] Chung, E.J., Cheng, Y., Morshed, R., Nord, K., Han, Y., Wegscheid, M.L., Auffinger, B., Wainwright, D.A., Lesniak, M.S., Tirrell, M.V., Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials 35 (2014), 1249–1256.
8. [8] Shin, T.-H., Choi, Y., Kim, S., Cheon, J., Recent advances in magnetic nanoparticle-based multi-modal imaging. Chem. Soc. Rev. 44 (2015), 4501–4516.
9. [9] Kim, J., Piao, Y., Hyeon, T., Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 38 (2009), 372–390.
10. [10] Lee, D.-E., Koo, H., Sun, I.-C., Ryu, J.H., Kim, K., Kwon, I.C., Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41 (2012), 2656–2672.
11. [11] Nam, T., Park, S., Lee, S.-Y., Park, K., Choi, K., Song, I.C., Han, M.H., Leary, J.J., Yuk, S.A., Kwon, I.C., Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. Bioconjug. Chem. 21 (2010), 578–582.
12. [12] Torres Martin de Rosales, R., Tavaré, R., Paul, R.L., Jauregui-Osoro, M., Protti, A., Glaria, A., Varma, G., Szanda, I., Blower, P.J., Synthesis of 64CuII–bis (dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET–MRI agent. Angew. Chem. Int. Ed. 50 (2011), 5509–5513.
13. [13] Li, S., Goins, B., Zhang, L., Bao, A., Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug. Chem. 23 (2012), 1322–1332.
14. [14] Fong, C., Le, T., Drummond, C.J., Lyotropic liquid crystal engineering–ordered nanostructured small molecule amphiphile self-assembly materials by design. Chem. Soc. Rev. 41 (2012), 1297–1322.
15. [15] Seddon, J., Templer, R., Polymorphism of lipid-water systems. Handb. Biol. Phys. 1 (1995), 97–160.
16. [16] Clogston, J., Caffrey, M., Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J. Control. Release 107 (2005), 97–111.
17. [17] Angelov, B., Angelova, A., Filippov, S.K., Drechsler, M., Štěpánek, P., Lesieur, S., Multicompartment lipid cubic nanoparticles with high protein upload: millisecond dynamics of formation. ACS Nano 8 (2014), 5216–5226.
18. [18] Angelova, A., Angelov, B., Mutafchieva, R., Lesieur, S., Couvreur, P., Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. Acc. Chem. Res. 44 (2010), 147–156.
19. [19] Mulet, X., Boyd, B.J., Drummond, C.J., Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions. J. Colloid Interface Sci. 393 (2013), 1–20.
20. [20] Caltagirone, C., Arca, M., Falchi, A.M., Lippolis, V., Meli, V., Monduzzi, M., Nylander, T., Rosa, A., Schmidt, J., Talmon, Y., Solvatochromic fluorescent BODIPY derivative as imaging agent in camptothecin loaded hexosomes for possible theranostic applications. RSC Adv. 5 (2015), 23443–23449.
21. [21] Negrini, R., Mezzenga, R., Diffusion, molecular separation, and drug delivery from lipid mesophases with tunable water channels. Langmuir 28 (2012), 16455–16462.
22. [22] Dong, Y.-D., Larson, I., Hanley, T., Boyd, B.J., Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir 22 (2006), 9512–9518.
23. [23] Tran, N., Hawley, A., Zhai, J., Muir, B.W., Fong, C., Drummond, C.J., Mulet, X., High-throughput screening of saturated fatty acid influence on nanostructure of lyotropic liquid crystalline lipid nanoparticles. Langmuir 32 (2016), 4509–4520.
24. [24] Zhai, J., Scoble, J.A., Li, N., Lovrecz, G., Waddington, L.J., Tran, N., Muir, B.W., Coia, G., Kirby, N., Drummond, C.J., Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity. Nanoscale 7 (2015), 2905–2913.
25. [25] Fong, W.-K., Negrini, R., Vallooran, J.J., Mezzenga, R., Boyd, B.J., Responsive self-assembled nanostructured lipid systems for drug delivery and diagnostics. J. Colloid Interface Sci. 484 (2016), 320–339.
26. [26] Tran, N., Mulet, X., Hawley, A.M., Hinton, T.M., Mudie, S.T., Muir, B.W., Giakoumatos, E.C., Waddington, L.J., Kirby, N.M., Drummond, C.J., Nanostructure and cytotoxicity of self-assembled monoolein-capric acid lyotropic liquid crystalline nanoparticles. RSC Adv. 5 (2015), 26785–26795.
27. [27] Hinton, T.M., Grusche, F., Acharya, D., Shukla, R., Bansal, V., Waddington, L.J., Monaghan, P., Muir, B.W., Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells. Toxicol. Res. 3 (2014), 11–22.
28. [28] Falchi, A.M., Rosa, A., Atzeri, A., Incani, A., Lampis, S., Meli, V., Caltagirone, C., Murgia, S., Effects of monoolein-based cubosome formulations on lipid droplets and mitochondria of HeLa cells. Toxicol. Res. 4 (2015), 1025–1036.
29. [29] Murgia, S., Falchi, A.M., Mano, M., Lampis, S., Angius, R., Carnerup, A.M., Schmidt, J., Diaz, G., Giacca, M., Talmon, Y., Nanoparticles from lipid-based liquid crystals: emulsifier influence on morphology and cytotoxicity. J. Phys. Chem. B 114 (2010), 3518–3525.
30. [30] Barauskas, J., Cervin, C., Jankunec, M., Špandyreva, M., Ribokaitė, K., Tiberg, F., Johnsson, M., Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Int. J. Pharm. 391 (2010), 284–291.
31. [31] Zhai, J., Hinton, T.M., Waddington, L.J., Fong, C., Tran, N., Mulet, X., Drummond, C.J., Muir, B.W., Lipid-PEG conjugates sterically stabilise and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles. Langmuir 31 (2015), 10871–10880.
32. [32] Zhai, J., Suryadinata, R., Luan, B., Tran, N., Hinton, T., Ratcliffe, J., Hao, X., Drummond, C.J., Amphiphilic brush polymers produced by the RAFT polymerisation method stabilise and reduce the cell cytotoxicity of lipid lyotropic liquid crystalline nanoparticles. Faraday Discuss. 191 (2016), 545–563.
33. [33] Shen, H.-H., Crowston, J.G., Huber, F., Saubern, S., McLean, K.M., Hartley, P.G., The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions. Biomaterials 31 (2010), 9473–9481.
34. [34] Rosa, A., Murgia, S., Putzu, D., Meli, V., Falchi, A.M., Monoolein-based cubosomes affect lipid profile in HeLa cells. Chem. Phys. Lipids 191 (2015), 96–105.
35. [35] Gong, X., Moghaddam, M.J., Sagnella, S.M., Conn, C.E., Mulet, X., Danon, S.J., Waddington, L.J., Drummond, C.J., Nanostructured self-assembly materials from neat and aqueous solutions of C18 lipid pro-drug analogues of Capecitabine—a chemotherapy agent. Focus on nanoparticulate cubosomes™ of the oleyl analogue. Soft Matter 7 (2011), 5764–5776.
36. [36] Jin, X., Zhang, Z.-h., Sun, E., Tan, X.-b., Li, S.-l., Cheng, X.-d., You, M., Jia, X.-b., Enhanced oral absorption of 20 (S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies. Int. J. Nanomedicine, 8, 2013, 641.
37. [37] Muir, B.W., Acharya, D.P., Kennedy, D.F., Mulet, X., Evans, R.A., Pereira, S.M., Wark, K.L., Boyd, B.J., Nguyen, T.-H., Hinton, T.M., Waddington, L.J., Kirby, N., Wright, D.K., Wang, H.X., Egan, G.F., Moffat, B.A., Metal-free and MRI visible theranostic lyotropic liquid crystal nitroxide-based nanoparticles. Biomaterials 33 (2012), 2723–2733.
38. [38] Nasr, M., Ghorab, M.K., Abdelazem, A., In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm. Sin. B 5 (2015), 79–88.
39. [39] Sagnella, S.M., Gong, X., Moghaddam, M.J., Conn, C.E., Kimpton, K., Waddington, L.J., Krodkiewska, I., Drummond, C.J., Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents. Nanoscale 3 (2011), 919–924.
40. [40] Yang, Z.W., Chen, M.W., Yang, M.H., Chen, J., Fang, W.J., Xu, P., Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection. Int. J. Nanomedicine 9 (2014), 327–336.
41. [41] Nilsson, C., Barrios-Lopez, B., Kallinen, A., Laurinmäki, P., Butcher, S.J., Raki, M., Weisell, J., Bergström, K., Larsen, S.W., Østergaard, J., SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications. Biomaterials 34 (2013), 8491–8503.
42. [42] Jain, V., Swarnakar, N.K., Mishra, P.R., Verma, A., Kaul, A., Mishra, A.K., Jain, N.K., Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy. Biomaterials 33 (2012), 7206–7220.
43. [43] Bye, N., Hutt, O.E., Hinton, T.M., Acharya, D., Waddington, L.J., Moffat, B.A., Wright, D.K., Wang, H., Mulet, X., Muir, B.W., Nitroxide loaded hexosomes provide MRI contrast in vivo. Langmuir 30 (2014), 8898–8906.
44. [44] Tran, N., Mulet, X., Hawley, A., Conn, C.E., Zhai, J., Waddington, L.J., Drummond, C.J., First direct observation of stable internally ordered Janus nanoparticles created by lipid self-assembly. Nano Lett. 15 (2015), 4229–4233.
45. [45] Tilley, A.J., Drummond, C.J., Boyd, B.J., Disposition and association of the steric stabilizer pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions. J. Colloid Interface Sci. 392 (2013), 288–296.
46. [46] Armas, R.R., Clinical studies with spleen-specific radiolabeled agents. Semin. Nucl. Med., 1985, 260–275 (Elsevier).
47. [47] Muir, B.W., Acharya, D.P., Kennedy, D.F., Mulet, X., Evans, R.A., Pereira, S.M., Wark, K.L., Boyd, B.J., Nguyen, T.-H., Hinton, T.M., Metal-free and MRI visible theranostic lyotropic liquid crystal nitroxide-based nanoparticles. Biomaterials 33 (2012), 2723–2733.
48. [48] Bulte, J.W., Kraitchman, D.L., Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17 (2004), 484–499.
49. [49] Idoyaga, J., Suda, N., Suda, K., Park, C.G., Steinman, R.M., Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen. Proc. Natl. Acad. Sci. 106 (2009), 1524–1529.
50. [50] Jain, N.K., Mishra, V., Mehra, N.K., Targeted drug delivery to macrophages. Expert Opin. Drug Deliv. 10 (2013), 353–367.
51. [51] Singodia, D., Verma, A., Verma, R.K., Mishra, P.R., Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery. Nanomed.: Nanotechnol., Biol. Med. 8 (2012), 468–477.
52. [52] Nahar, M., Dubey, V., Mishra, D., Mishra, P.K., Dube, A., Jain, N.K., In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis. J. Drug Target. 18 (2010), 93–105.
53. [53] Dutta, T., Garg, M., Jain, N.K., Targeting of efavirenz loaded tuftsin conjugated poly (propyleneimine) dendrimers to HIV infected macrophages in vitro. Eur. J. Pharm. Sci. 34 (2008), 181–189.
54. [54] Prajapati, V.K., Awasthi, K., Gautam, S., Yadav, T.P., Rai, M., Srivastava, O.N., Sundar, S., Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. J. Antimicrob. Chemother. 66 (2011), 874–879.
55. [55] Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., Weinmann, H.-J., Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Investig. Radiol. 40 (2005), 715–724.
56. [56] Angelova, A., Ollivon, M., Campitelli, A., Bourgaux, C., Lipid cubic phases as stable nanochannel network structures for protein biochip development: X-ray diffraction study. Langmuir 19 (2003), 6928–6935.
57. [57] Fraser, S.J., Mulet, X., Martin, L., Praporski, S., Mechler, A., Hartley, P.G., Polyzos, A., Separovic, F., Surface immobilization of bio-functionalized cubosomes: sensing of proteins by quartz crystal microbalance. Langmuir 28 (2011), 620–627.